Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate

BACKGROUND/AIMS: To investigate the treatment efficacy and renal safety of long-term tenofovir disoproxil fumarate (TDF) therapy in chronic hepatitis B (CHB) patients with preserved renal function. METHODS: The medical records of 919 CHB patients who were treated with TDF therapy were reviewed. All...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, In Suk, Lee, Chang Hun, Shin, Ik Sang, Lee, Na Eun, Son, Hong Seon, Kim, Seung Bum, Seo, Seung Young, Kim, Seong Hun, Kim, Sang Wook, Lee, Seung Ok, Lee, Soo Teik, Kim, In Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347000/
https://www.ncbi.nlm.nih.gov/pubmed/30400723
http://dx.doi.org/10.5009/gnl18183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347000/
https://www.ncbi.nlm.nih.gov/pubmed/30400723
http://dx.doi.org/10.5009/gnl18183

Ejemplares similares